Earnings History Data for Cartesian Therapeutics, Inc. (RNAC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cartesian Therapeutics, Inc.
Selecta Biosciences, Inc. is a biopharmaceutical company which develops targeted immunotherapies and vaccines. Its product pipelineincludes gene therapy, food allergy, malaria; SEL-212, which is a therapeutic enzyme indicated for refractory gout; SEL-070, which is indicated for smoking cessation and relapse prevention; SEL-701, which is indicated for the treatment of human papillomavirus associated cancer and SEL-212 consists of SVP-Rapamycin co-administered with pegsiticase, its pegylated uricase. Selecta Biosciences, Inc. is based in Watertown, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | RNAC | Cartesian Therapeutics, Inc. | 423.00 | -0.69 | -0.78 | 0.00 | 21.06 | 0.20 (0.96%) |
20.86 | 0.0 (0.00%) |
11.66 - 42.60 | 82,114 | 80,000 | 2,517 | |||
|
|
||||||||||||||||||
| 08-08-2024 | PM | RNAC | Cartesian Therapeutics, Inc. | 317.00 | 0.54 | -0.81 | 0.00 | Cartesian Therapeutics GAAP EPS of $0.54, revenue of $33.45M [8/8/2024 7:56 AM] |
13.17 | -1.04 (-7.32%) |
0.0 | 0.0 (0.00%) |
11.66 - 42.60 | 129,143 | 80,000 | 0 | ||
| 08-05-2024 | PM | RNAC | Cartesian Therapeutics, Inc. | 138.00 | -1.97 | -0.81 | 0.00 | Cartesian Therapeutics GAAP EPS of -$10.50, revenue of $5.84M [5/8/2024 11:22 AM] |
23.25 | 0.05 (0.19%) |
22.05 | -1.15 (-4.98%) |
11.66 - 42.60 | 40,791 | 110,000 | 207 | ||